GlobeImmune, Inc.
GBIM
$0.0002
$0.000.00%
OTC PK
| 03/31/2016 | 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | |
|---|---|---|---|---|---|
| Net Income | 86.55% | 82.99% | 3.95% | -713.10% | -279.14% |
| Total Depreciation and Amortization | -58.13% | -36.55% | -27.71% | -36.82% | -51.02% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -94.86% | 61.13% |
| Total Other Non-Cash Items | -100.51% | -100.11% | -100.21% | 254.18% | 600.13% |
| Change in Net Operating Assets | -13.01% | -0.34% | 70.48% | 60.33% | 50.03% |
| Cash from Operations | 35.83% | 29.07% | 2.01% | -2,754.95% | -520.13% |
| Capital Expenditure | 96.22% | 87.87% | 65.02% | 10.45% | -3,801.25% |
| Sale of Property, Plant, and Equipment | -- | 99.14% | 88.38% | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 177.51% | 230.62% | 231.94% | -237.91% | -361.61% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -99.93% | 63,131.87% | 360,000.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -150.13% | -150.13% |
| Cash from Financing | -- | -- | -99.94% | 125.95% | 127.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -210.15% | -163.48% | -158.20% | -3.69% | -41.33% |